The precision medicine concept is being applied robustly in caring for rare diseases. Although it is more popular in oncology, it is gradually spreading to other specialties. The rising prevalence of cancer and the growing incidence of rare neurological disorders are increasing the demand for precision medicine, driving the growth of the precision diagnostics market. In addition, the rising demand for treatment procedures in oncology and other disorders is surging the adoption of treatment procedures. The genetic test is helpful in many areas of medicine as it identifies mutations or variants in the DNA. Genetic testing, for example, provides information about the risk of developing cancer and diagnose genetic conditions, such as Fragile X syndrome or Huntington's disease.
Moreover, the growing number of strategic collaborations between biopharmaceutical companies, to develop medicines targeted to treat a specific group of patients based on their particular needs and to provide effective treatment procedures and services, is increasing the number of clinical trials. The factors mentioned above are driving the precision diagnostics market growth.
The South & Central America precision diagnostics market is segmented by type, application, end user, and country. Based on type, the market is segmented into genetic tests, esoteric tests, and others. The genetic tests segment dominated the market in 2022.
A few key players dominating the South & Central America precision diagnostics market are Abbott, Bayer AG, Koninklijke Philips N.V., Novartis AG, QIAGEN, Quest Diagnostics Incorporated, Sanofi, Siemens Healthineers AG, and Swiss Precision Diagnostics GmbH.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 4,523.35 Million |
| Market Size by 2028 | US$ 9,009.71 Million |
| CAGR (2022 - 2028) | 12.2% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South & Central America Precision Diagnostics Market is valued at US$ 4,523.35 Million in 2022, it is projected to reach US$ 9,009.71 Million by 2028.
As per our report South & Central America Precision Diagnostics Market, the market size is valued at US$ 4,523.35 Million in 2022, projecting it to reach US$ 9,009.71 Million by 2028. This translates to a CAGR of approximately 12.2% during the forecast period.
The South & Central America Precision Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Precision Diagnostics Market report:
The South & Central America Precision Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Precision Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Precision Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Precision Diagnostics Market
